-
Product Insights
Diarrhea Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Diarrhea is a contagious gastrointestinal infection occurring mostly due to unhygienic conditions. Diarrhea may be related to a viral or bacterial infection and is sometimes the result of food poisoning. Symptoms include nausea, abdominal pain, cramping, bloating, dehydration, fever, bloody stools, frequent urge to evacuate the bowels, and incontinence. Treatment includes medication and a healthy lifestyle. The Diarrhea Drugs in Development market research report provides an overview of the diarrhea pipeline landscape. The report provides comprehensive information on the therapeutics...
-
Product Insights
Batten Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Batten disease, a rare genetic disorder, belongs to a group of progressive degenerative neurometabolic disorders known as neuronal ceroid lipofuscinoses. Symptoms include vision loss, lack of muscle coordination, mental retardation or decreasing mental function, emotional disturbances, seizures, muscle spasms, deterioration of muscle tone, and movement problems. The Batten Disease Drugs in Development market research report provides an overview of the Batten Disease pipeline landscape. The report provides comprehensive information on the therapeutics under development for Batten Disease, complete with analysis...
-
Product Insights
Granulomatosis with Polyangiitis (Wegener’s Granulomatosis) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Wegener Polyangiitis is an uncommon disorder that causes inflammation of blood vessels. This inflammation restricts blood flow to various organs. Signs and symptoms include constantly runny nose, nose bleeds, ear infections, cough, chest pain, skin sores, and fever. Predisposing factor includes age. Treatment includes immunosuppressive and corticosteroids. The Granulomatosis with Polyangiitis drugs in development market research report provides comprehensive information on the therapeutics under development for Granulomatosis with Polyangiitis, complete with analysis by stage of development, drug target, mechanism of...
-
Sector Analysis
United States Wound Care Management Market Outlook to 2025 – Advanced Wound Management, Compression Therapy, Negative Pressure Wound Therapy (NPWT) and Others
GlobalData’s “United States Wound Care Management Market Outlook to 2025” is a comprehensive databook report, covering key market data on the United States Wound Care Management market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Advanced Wound Management, Compression Therapy, Negative Pressure Wound Therapy (NPWT), Ostomy Drainage Bags, Oxygen Therapy Devices, Pressure Relief Devices, Surgical Sutures, Tissue Engineered - Skin Substitutes, Traditional Wound Management, Wound Closure Devices and Wound Debridement Devices. The...
-
Sector Analysis
United States Cardiovascular Devices Market Outlook to 2025 – Aortic and Vascular Graft Devices, Atherectomy Devices, Cardiac Assist Devices and Others
GlobalData’s “United States Cardiovascular Devices Market Outlook to 2025” is a comprehensive databook report, covering key market data on the United States Cardiovascular Devices market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Aortic and Vascular Graft Devices, Atherectomy Devices, Cardiac Assist Devices, Cardiac Rhythm Management Devices, Cardiovascular Prosthetic Devices, Cardiovascular Surgery Devices, Clot Management Devices, Electrophysiology Devices, Interventional Cardiology, Peripheral Vascular Devices and Prosthetic Heart Valves. The United States Cardiovascular Devices...
-
Case Studies
Success Case Study: Goop – Positioning wellness as a status symbol
"Success Case Study: Goop", is part of GlobalData's Successes and Failures research. It focuses on the US lifestyle brand Goop, which has found success by sitting at the junction of health and indulgence, thus premiumizing the notion of wellness. The case study delivers crucial "what?", "why?", and "so what?" analysis to impart valuable lessons that can increase the prospects of a successful product launch. The concepts of health and indulgence are often at odds from a marketing perspective. Health is...
-
Product Insights
Oppositional Defiant Disorder (ODD) Global Clinical Trials Review, H1, 2018
GlobalData's clinical trial report, “Oppositional Defiant Disorder (ODD) Global Clinical Trials Review, H1, 2018" provides an overview of Oppositional Defiant Disorder (ODD) clinical trials scenario. This report provides top line data relating to the clinical trials on Oppositional Defiant Disorder (ODD). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and...
-
Product Insights
Oppositional Defiant Disorder (ODD) Global Clinical Trials Review, H2, 2016
GlobalData's clinical trial report, “Oppositional Defiant Disorder (ODD) Global Clinical Trials Review, H2, 2016" provides an overview of Oppositional Defiant Disorder (ODD) clinical trials scenario. This report provides top line data relating to the clinical trials on Oppositional Defiant Disorder (ODD). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and...
-
Sector Analysis
UK Personal Injury Litigation 2016; The turbulent course of market-changing reform continues
The personal injury sector continues its turbulent course of market-changing reform, with legislative, legal, and regulatory forces at work. While the market was just beginning to settle post-Legal Aid, Sentencing and Punishment of Offenders Act 2012 (LASPO), the game-changing reforms announced by the government in November 2015 have once again whipped up a storm of uncertainty.